PTPN11 and Noonan syndrome: Two mutations associated with Noonan Syndrome (NS) were included: T42A, which alters N-SH2 binding affinity and specificity19,44, and E139D, a C-SH2 mutation that enhances SHP2 basal catalytic activity but does not appear to affect SH2 binding functions18,19.